| Abby J Stroeh, DO | |
|
1801 Hickman Rd, Des Moines, IA 50314-1505 | |
| (515) 282-5640 | |
| Not Available |
| Full Name | Abby J Stroeh |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 1801 Hickman Rd, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255823951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-11255 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | DO-05425 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sioux Center Health | Sioux center, IA | Hospital |
| Pleasant Acres Care Center | Hull, IA | Nursing home |
| Sioux Center Health Royale Meadows | Sioux center, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sioux Center Health | 9032027495 | 29 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.
A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).
› Verified 7 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.
A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).
› Verified 7 days ago
| Entity Name | Sioux Center Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669542981 PECOS PAC ID: 9032027495 Enrollment ID: O20040224001315 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.
A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).
› Verified 7 days ago
| Entity Name | Sioux Center Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1326056755 PECOS PAC ID: 9032027495 Enrollment ID: O20070123000516 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.
A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abby J Stroeh, DO 1801 Hickman Rd, Des Moines, IA 50314-1505 Ph: (515) 282-5640 | Abby J Stroeh, DO 1801 Hickman Rd, Des Moines, IA 50314-1505 Ph: (515) 282-5640 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.
A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that its automated patient eligibility and benefits verification tool, Emdeon® Assistant™, and web-based billing management solution, Emdeon Claim Master®, have earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA). The HFMA Peer Reviewed designation places these Emdeon solutions on a short list of prestigious products that have been proven effective by industry expert volunteers and independent HFMA staff.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).
› Verified 7 days ago
Neetha Molakala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 University Ave, Suite 120, Des Moines, IA 50314 Phone: 515-248-1500 Fax: 515-248-1510 | |
Matthew Helmick Williams, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-5640 Fax: 515-282-2332 | |
Todd Eberle, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8678 Fax: 515-643-5802 | |
Evan Douglas Peterson, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6520 Se 14th St, Des Moines, IA 50320 Phone: 515-953-1500 Fax: 515-953-2136 | |
April Winters, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2353 Se 14th St, Des Moines, IA 50320 Phone: 515-248-1400 Fax: 515-248-1414 | |
Kelli A Roenfanz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 East University Avenue, Des Moines, IA 50316 Phone: 515-265-4211 Fax: 515-309-5993 | |
Dr. Sarah Sweeney Gude, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3509 E 29th St, Des Moines, IA 50317 Phone: 515-248-1600 Fax: 515-248-1610 |